The role of the L-arginine-nitric oxide pathway in preeclampsia

15 p.

Autores:
Lopez-Jaramillo, Patricio
Arenas, William D.
García, Ronald G.
Rincón, Melvin Y.
López Casillas, Marcos
Tipo de recurso:
Article of journal
Fecha de publicación:
2008
Institución:
Universidad de Santander
Repositorio:
Repositorio Universidad de Santander
Idioma:
eng
OAI Identifier:
oai:repositorio.udes.edu.co:001/3691
Acceso en línea:
https://repositorio.udes.edu.co/handle/001/3691
Palabra clave:
Preeclampsia
Endothelium
Nitric oxide
Inflammation
Infection
Rights
openAccess
License
Derechos Reservados - Therapeutic Advances in Cardiovascular Disease, 2008
id RUDES2_30fdf24955dec9aab19a3388e8d3ac33
oai_identifier_str oai:repositorio.udes.edu.co:001/3691
network_acronym_str RUDES2
network_name_str Repositorio Universidad de Santander
repository_id_str
dc.title.eng.fl_str_mv The role of the L-arginine-nitric oxide pathway in preeclampsia
title The role of the L-arginine-nitric oxide pathway in preeclampsia
spellingShingle The role of the L-arginine-nitric oxide pathway in preeclampsia
Preeclampsia
Endothelium
Nitric oxide
Inflammation
Infection
title_short The role of the L-arginine-nitric oxide pathway in preeclampsia
title_full The role of the L-arginine-nitric oxide pathway in preeclampsia
title_fullStr The role of the L-arginine-nitric oxide pathway in preeclampsia
title_full_unstemmed The role of the L-arginine-nitric oxide pathway in preeclampsia
title_sort The role of the L-arginine-nitric oxide pathway in preeclampsia
dc.creator.fl_str_mv Lopez-Jaramillo, Patricio
Arenas, William D.
García, Ronald G.
Rincón, Melvin Y.
López Casillas, Marcos
dc.contributor.author.spa.fl_str_mv Lopez-Jaramillo, Patricio
Arenas, William D.
García, Ronald G.
Rincón, Melvin Y.
López Casillas, Marcos
dc.subject.proposal.eng.fl_str_mv Preeclampsia
Endothelium
Nitric oxide
Inflammation
Infection
topic Preeclampsia
Endothelium
Nitric oxide
Inflammation
Infection
description 15 p.
publishDate 2008
dc.date.issued.spa.fl_str_mv 2008-08-01
dc.date.accessioned.spa.fl_str_mv 2019-08-29T16:56:05Z
dc.date.available.spa.fl_str_mv 2019-08-29T16:56:05Z
dc.type.spa.fl_str_mv Artículo de revista
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.content.spa.fl_str_mv Text
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.redcol.spa.fl_str_mv http://purl.org/redcol/resource_type/ART
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_6501
status_str publishedVersion
dc.identifier.doi.spa.fl_str_mv 10.1177/1753944708092277
dc.identifier.issn.spa.fl_str_mv 1753-9455
1753-9447
dc.identifier.uri.spa.fl_str_mv https://repositorio.udes.edu.co/handle/001/3691
identifier_str_mv 10.1177/1753944708092277
1753-9455
1753-9447
url https://repositorio.udes.edu.co/handle/001/3691
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartof.eng.fl_str_mv Therapeutic Advances in Cardiovascular Disease
dc.relation.ispartofseries.eng.fl_str_mv Therapeutic Advances in Cardiovascular Disease;Vol. 2 (4), pp. 261-275. 2008
dc.rights.spa.fl_str_mv Derechos Reservados - Therapeutic Advances in Cardiovascular Disease, 2008
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.creativecommons.spa.fl_str_mv Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
rights_invalid_str_mv Derechos Reservados - Therapeutic Advances in Cardiovascular Disease, 2008
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
https://creativecommons.org/licenses/by-nc/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.source.eng.fl_str_mv https://journals.sagepub.com/doi/pdf/10.1177/1753944708092277
institution Universidad de Santander
bitstream.url.fl_str_mv https://repositorio.udes.edu.co/bitstreams/b514ae40-8c67-494f-85da-9cfab2c3631b/download
https://repositorio.udes.edu.co/bitstreams/f697a9c3-6722-4b9f-b248-70b45fee9941/download
https://repositorio.udes.edu.co/bitstreams/f2aab1c9-5db3-4ee5-b6b1-4ed8f9232c1c/download
https://repositorio.udes.edu.co/bitstreams/701e9587-d600-4fcf-8f9b-5b1d652cd86d/download
bitstream.checksum.fl_str_mv 1360aa8ba4672002ad1e9ec7c13c893c
38d94cf55aa1bf2dac1a736ac45c881c
6ec20b9679f5c477aedbc2933fde092b
a9edc3d872770a023f5076acd7a196fa
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Universidad de Santander
repository.mail.fl_str_mv soporte@metabiblioteca.com
_version_ 1814158797346701312
spelling Lopez-Jaramillo, Patricio9a71267b-dcb0-4d31-b37d-2d30be58d4d2-1Arenas, William D.a776bc8f-583d-45a0-b958-c4982c17557b-1García, Ronald G.41c4b822-ac96-4ffc-ac48-9d3227b75257-1Rincón, Melvin Y.7a43a890-d706-4c22-895c-54683fec12bc-1López Casillas, Marcosd77850e1-b3f1-4c4b-95bd-26c376e92c62-12019-08-29T16:56:05Z2019-08-29T16:56:05Z2008-08-0115 p.: Preeclampsia (PE) is a major cause of maternal and perinatal mortality, especially in developing countries. Its etiology involves multiple factors, but no specific cause has been identified. Evidence suggests that clinical manifestations are caused by endothelial dysfunction. Nitric oxide (NO), which is synthesized from L-arginine in endothelial cells by the endothelial nitric oxide synthase (eNOS), provides a tonic dilator tone and regulates the adhesion of white blood cells and platelet aggregation. Alterations in the L-arginine-NO pathway have been associated with the development of PE. Various studies, reporting decreased, elevated or unchanged levels of nitrite (NO2) and nitrate (NO3), two end products of NO metabolism, have been published. Our group contributed to those contradictory reports describing cases of PE with both elevated and decreased levels of NO2 and NO3. Apparently, diminished levels of NO could be related to deficiencies in the ingestion of dietary calcium associated to low levels of plasma ionic calcium, which is crucial to the eNOS’ activity. Also, low levels of NO could be associated with the presence of eNOS polymorphisms or the presence of increased levels of ADMA, the endogenous inhibitor of NO. High levels of NO associated to low levels of cGMP suggest a decreased bioactivity of NO, which is probably related to an increased degradation of NO caused by a high production of superoxide in states of infection and inflammation. The present article analyses and reviews the reported paradoxical roles of the L-arginine-NO pathway in PE and gives a possible explanation for these results.application/pdf10.1177/17539447080922771753-94551753-9447https://repositorio.udes.edu.co/handle/001/3691engTherapeutic Advances in Cardiovascular DiseaseTherapeutic Advances in Cardiovascular Disease;Vol. 2 (4), pp. 261-275. 2008Derechos Reservados - Therapeutic Advances in Cardiovascular Disease, 2008info:eu-repo/semantics/openAccessAtribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/http://purl.org/coar/access_right/c_abf2https://journals.sagepub.com/doi/pdf/10.1177/1753944708092277PreeclampsiaEndotheliumNitric oxideInflammationInfectionThe role of the L-arginine-nitric oxide pathway in preeclampsiaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1Textinfo:eu-repo/semantics/articlehttp://purl.org/redcol/resource_type/ARTinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/version/c_970fb48d4fbd8a85PublicationORIGINALThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdfThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdfapplication/pdf296478https://repositorio.udes.edu.co/bitstreams/b514ae40-8c67-494f-85da-9cfab2c3631b/download1360aa8ba4672002ad1e9ec7c13c893cMD56LICENSElicense.txtlicense.txttext/plain; charset=utf-859https://repositorio.udes.edu.co/bitstreams/f697a9c3-6722-4b9f-b248-70b45fee9941/download38d94cf55aa1bf2dac1a736ac45c881cMD52TEXTThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdf.txtThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdf.txtExtracted texttext/plain58224https://repositorio.udes.edu.co/bitstreams/f2aab1c9-5db3-4ee5-b6b1-4ed8f9232c1c/download6ec20b9679f5c477aedbc2933fde092bMD53THUMBNAILThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdf.jpgThe role of the L-arginine-nitric oxide pathway in preeclampsia.pdf.jpgGenerated Thumbnailimage/jpeg1813https://repositorio.udes.edu.co/bitstreams/701e9587-d600-4fcf-8f9b-5b1d652cd86d/downloada9edc3d872770a023f5076acd7a196faMD54001/3691oai:repositorio.udes.edu.co:001/36912023-10-10 08:31:03.898https://creativecommons.org/licenses/by-nc/4.0/Derechos Reservados - Therapeutic Advances in Cardiovascular Disease, 2008https://repositorio.udes.edu.coRepositorio Universidad de Santandersoporte@metabiblioteca.comTGljZW5jaWEgZGUgUHVibGljYWNpw7NuIFVERVMKRGlyZWN0cmljZXMgZGUgVVNPIHkgQUNDRVNPCgo=